Q1: Subsequent Transplant of Cellular Therapy

Question 1: Is this the report of a second or subsequent transplant or cellular therapy for the same disease?

If this is a report of a second or subsequent transplant / cellular therapy for the same disease subtype and this baseline disease insert was not completed for the previous transplant (e.g., patient was on TED track for the prior HCT, prior HCT was autologous with no consent, etc.), continue with question 2.

If this is a report of a second or subsequent transplant / cellular therapy for a different disease (e.g., patient was previously transplanted for a disease other than MDS), begin at question 2.

If this is a report of a second or subsequent transplant / cellular therapy for the same disease and this baseline disease insert has previously been completed, select “yes” and continue with question 48.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.